Discuss all your medical conditions and medications with your healthcare provider before starting semaglutide
GLP-1 therapy is typically recommended for adults with: - BMI 30 (obesity) - BMI 27 with a weight-related health condition (type 2 diabetes, hypertension, sleep apnea) A medical evaluation is required
Researchers have suggested genetics, altered microbiomes, and other medications that promote weight gain as possible reasons for this
Patients have reported experiencing gastrointestinal blockages, gallbladder disease, and anterior ischemic optic neuropathy (NAION) after extended Rybelsus use
[3] [51] [272] The class includes amphetamine itself, stimulants like methamphetamine, serotonergic empathogens like MDMA, and decongestants like ephedrine, among other subgroups